Medical, News Headlines

HairClone Developing Personalized Cell Replacement Therapies

HairClone Developing Personalized Cell Replacement Therapies

Manchester, UK. 12/18 – Hairclone, is a startup company formed by a partnership of Scientists, Hair Transplant Surgeons and Patients to develop cutting-edge treatments for baldness. The most common type of hair loss is caused by hair follicles losing their regenerative abilities, causing them to miniaturize and create the appearance of thinning or balding. HairClone is developing a treatment to replace these lost cells. A few of a patient’s non-affected follicles will be harvested in a simple out-patient procedure. Potent cells will then be isolated from these fol-licles, multiplied in the laboratory, and micro-injected into the affected part of the scalp with the intention of rejuvenating the hair shafts, mak-ing them thicker and longer. Hairclone also plans to start the world’s first hair follicle bio-bank in 2019. Bio-banking will allow patients to store a small number of their hair follicles at the earliest age. These can be held in reserve and used for future hair loss treatments.

One thought on “HairClone Developing Personalized Cell Replacement Therapies”

  1. Tim Marks says:

    Male and female patients who are concerned about hair loss can now have some of their hair follicles cryopreserved and stored for future available treatments.